Malignant immunoproliferative diseases

CD2_IMMUNOPROLIFERATIVE

lymphoma: A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Hospital Discharge: ICD-10 C88

Hospital discharge: ICD-9 $!$

Hospital discharge: ICD-8 $!$

Cause of death: ICD-10 C88

Cause of death: ICD-9 $!$

Cause of death: ICD-8 $!$

168

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

168

Check minimum number of events None

168

Include endpoints None

168

CD2_IMMUNOPROLIFERATIVE

Extra metadata

Level in the ICD hierarchy 3

First used in FinnGen datafreeze DF4

Parent code in ICD-10 C81-C96

Name in latin Morbi immunoproliferativi maligni

Similar endpoints

↥

List of similar endpoints to Malignant immunoproliferative diseases based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	162	71	91
Unadjusted prevalence (%)	0.05	0.04	0.07
Mean age at first event (years)	65.40	64.51	66.09

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	-	-	-	-
15 years	-	-	-	-
5 years	-	-	-	-
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: CD2_IMMUNOPROLIFERATIVE – Malignant immunoproliferative diseases
GWS hits: 1

Survival analyses between endpoints

↥

Plot

before Malignant immunoproliferative diseases
after Malignant immunoproliferative diseases

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Malignant immunoproliferative diseases

↥